Previous 10 | Next 10 |
PALO ALTO, Calif. , Feb. 28, 2019 /PRNewswire/ -- In a ceremony officiated by the Regional Council of Central Denmark Region, Anders Kühnau, and attended by both the Danish Prime Minister Lars Løkke Rasmussen, and the Chairman of the A.P. Møller Foundation, Ane Maers...
PALO ALTO, Calif. and IDI-ARABA, LAGOS, Nigeria , Feb. 26, 2019 /PRNewswire/ -- At a ceremony in Idi-Araba, Lagos, Nigeria , Varian (NYSE: VAR) joined H.E. President Muhammadu Buhari, President of the Federal Republic of Nigeria , and other dignitaries to commission the NSIA-LUTH...
PALO ALTO, Calif. , Feb. 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute, a Proton International facility, has joined the FlashForward ™ Consortium. Now including 14 members, the consortium is focused on preclinical...
As we know, the stock market has charted something of a “V” pattern since early December, with the bottom point having occurred around Christmas. And right now, the S&P 500 is within a whisker of the early December high, the point from which the market started to draw the do...
LOS ANGELES, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Varian Medical Systems, Inc. (NYSE: VAR ) investors concerning the Company and its directors’ and officers’ possible violations of s...
PALO ALTO, Calif. , Feb. 6, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Eclipse ™ treatment planning system and TrueBeam® treatment system have been named Category Leaders in the 2019 Best in KLAS: Software and Services Report by KLAS, an independent research ...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
PALO ALTO, Calif. , Feb. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMSS19, booth 6143. Envisioning a world without fear of cancer, Varian builds and deliv...
NEW YORK, Feb. 01, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Exelixis, Inc. (NASDAQ:EXEL), Varian Medical Systems, Inc. (NYSE:VAR), DXC Tec...
News, Short Squeeze, Breakout and More Instantly...
Varian Medical Systems Inc. Company Name:
VAR Stock Symbol:
NYSE Market:
Varian Medical Systems Inc. Website:
Varian Announces First Participant Treated in GENESIS II Clinical Trial of Genicular Artery Embolization for Knee Osteoarthritis PR Newswire PALO ALTO, Calif. , Nov. 17, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the...
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy PR Newswire – Results published in JAMA Oncology and presented at ASTRO dem...